| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.69 | 0.01 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |